Bellevue Healthcare Trust plc (LON:BBH - Get Free Report) insider Randeep Singh Grewal acquired 324 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was acquired at an average price of GBX 154 ($1.93) per share, for a total transaction of £498.96 ($626.36).
Bellevue Healthcare Trust Trading Down 0.7 %
Shares of BBH opened at GBX 149.60 ($1.88) on Thursday. The company has a market cap of £817.79 million and a price-to-earnings ratio of 935.00. Bellevue Healthcare Trust plc has a 1-year low of GBX 119.40 ($1.50) and a 1-year high of GBX 159.80 ($2.01). The company's fifty day simple moving average is GBX 150.66 and its 200 day simple moving average is GBX 141.87.
Bellevue Healthcare Trust Announces Dividend
The firm also recently announced a dividend, which will be paid on Friday, May 31st. Stockholders of record on Thursday, May 9th will be given a GBX 3 ($0.04) dividend. The ex-dividend date of this dividend is Thursday, May 9th. This represents a dividend yield of 1.98%. Bellevue Healthcare Trust's payout ratio is presently 3,750.00%.
Bellevue Healthcare Trust Company Profile
(
Get Free Report)
Bellevue Healthcare Trust plc is a closed ended equity mutual fund launched by Bellevue Asset Management AG. The fund is managed by Bellevue Advisors Limited. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across healthcare sector. It seeks to benchmark the performance of its portfolio against the MSCI World Healthcare Index.
Featured Stories
Charles Payne’s Gift to Stock Investors
From Unstoppable Prosperity | Ad
Right now, millions of good honest folks are feeling the squeeze.
Last year's terrible market did a number on their accounts.
Stock values plunged.
Retirement accounts lost too.
Watch Insider's Advantage Event Tuesday at 4:00 PM ET
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
